SnagRX Semaglutide

SnagRX lists Compounded semaglutide injection at $99 a month, continuing. Medication is included in that catalog price. Readers deciding whether SnagRx belongs on their compounded semaglutide shortlist and who need treatment-level facts before comparing providers. The commercial terms were checked 22 October 2026; state access, clinician approval, dispensing details, and personal suitability remain separate questions.

We may earn a commission if you start a program through links on this page. It doesn't change prices or how we sort them. Disclosure

Visit SnagRX Affiliate link · we may earn a commissionView the provider profile
SnagRX Semaglutide treatment illustration
$99a month, continuing
Includedmedication in published price
Weekly subcutaneous injectionlisted format
22 October 2026commercial terms checked
1 listed restrictionpublished state availability

A treatment-specific read of the provider: SnagRX Semaglutide

Assess SnagRx's compounded semaglutide record, including the current pricing basis and format, while keeping it distinct from SnagRx's compounded tirzepatide option.

Readers deciding whether SnagRx belongs on their compounded semaglutide shortlist and who need treatment-level facts before comparing providers. The page therefore answers a bounded question: what SnagRX currently publishes for this exact Semaglutide offer and what still needs confirmation.

Total charge and plan duration: SnagRX Semaglutide

The published offer has both a continuing option at $99 a month, continuing and a prepaid option at $69 a month, paying $828 for 12 months up front. Those are different commitments. Compare the total charged today, the renewal path, and the cancellation deadline rather than treating the lowest monthly equivalent as month to month. For SnagRX's Semaglutide offer, distinguish the introductory charge, continuing charge, upfront payment and required commitment. A monthly equivalent can be useful, but only when the required payment and term remain visible beside it.

The SnagRX price source for this offer was checked on 22 October 2026. Before paying for Semaglutide, compare the amount charged today with the amount charged later, the number of months purchased, the renewal date, the cancellation window, and the refund boundary after clinical or pharmacy processing. A published price cannot safely answer those policy questions unless the cited provider evidence does.

How to interpret the current offer: SnagRX

SnagRX lists Compounded semaglutide injection at $99 a month, continuing, checked 22 October 2026. Read the amount together with the billing interval and any promotion or prepayment shown beside it. A lower monthly equivalent may require a longer commitment and a larger charge today. The linked price source is dated evidence of the advertised offer, not an independently verified checkout total or a guarantee that every dose and plan costs the same.

The published price includes medication. It does not verify that labs, every consultation, supplies, expedited shipping, or future dose changes are included unless the source says so. Those items remain checkout questions. For SnagRX Semaglutide, read medication inclusion as one part of the offer, not as proof that every service surrounding the prescription is free. The dated source establishes the advertised basis; it does not independently audit the final checkout, dispensing event, or quality of care.

The exact product and what it does not establish: Compounded semaglutide injection

Compounded semaglutide injection is listed as a compounded product in Weekly subcutaneous injection format. FDA states that compounded drugs are not FDA-approved and do not receive the same premarket review as approved drug products. Ask for the exact formulation and dispensing pharmacy before purchase. That status is central to this SnagRX guide because a related medication name does not make branded, compounded, oral, nasal, and injectable products interchangeable.

SnagRX lists Compounded semaglutide injection in Weekly subcutaneous injection format. The Compounded semaglutide injection comparison groups offers with the same treatment and route so their prices can be assessed fairly. A shared medication name does not make different formulations interchangeable. This guide does not provide dose instructions or route conversions, and it does not establish that another formulation has the same evidence, safety profile, convenience or outcomes.

Operational evidence worth carrying forward: SnagRX

The linked sources identify Red Rock Compounding Pharmacy, Health Warehouse, Precision Compounding, and Triad Rx as SnagRX's pharmacy. SnagRX names these partner pharmacies; assignment varies. Quoted from SnagRX's homepage: "Red Rock Compounding Pharmacy (St. George, UT)". These entities can perform different jobs, so the consumer-facing brand should not automatically be described as the clinician or dispensing pharmacy for Semaglutide.

HSA/FSA cards: Quoted from SnagRX's semaglutide page: "FSA/HSA eligible"; its terms add "We do not guarantee that any amounts paid are eligible for reimbursement by insurance, HSA/FSA, or otherwise." An unresolved issue for SnagRX's Semaglutide offer remains: Recent state copy changed: The live FAQ excludes Louisiana while a recently cached alert also excluded Mississippi; no 49-state count is published. Ask the provider how that issue affects the selected order. A published price does not resolve uncertainty about billing, fulfillment, eligibility or the terms that apply after payment.

Availability and its limits: Semaglutide

Published availability lists Louisiana as restricted for weight-loss programs. That list reflects the sources checked on the date shown; it does not prove eligibility everywhere else. Confirm the current state rule before intake. The Semaglutide access check belongs near the price because a low published figure has little decision value when SnagRX cannot serve the reader's state or the selected product cannot be fulfilled there.

For SnagRX Semaglutide, the consumer brand, administrative platform, clinical group, and dispensing pharmacy can be different entities. A provider page may describe a national service while licensure, product rules, and pharmacy coverage narrow actual fulfillment. Ask which clinician entity would review the intake and which licensed pharmacy would dispense this exact product in the reader's state before treating access as settled.

Move from this guide to the full comparison: Semaglutide

The linked Semaglutide comparison places SnagRX beside other providers with published prices. Check the same details for every offer: continuing price, introductory period, required prepayment, medication inclusion, product type, delivery format, verification date, and state evidence. If two offers use different routes or one price excludes medication, a simple lowest-number verdict would not be a like-for-like conclusion.

Use the comparison link to check other Semaglutide offers, then open SnagRX's site to confirm the selected product. A provider may list several related treatments or plan lengths on the same page. Make sure the intake and checkout still name Compounded semaglutide injection, use the weekly subcutaneous injection format, and show the same medication inclusion and billing basis before treating the two offers as equivalent.

Decision summary: SnagRX Semaglutide

The responsible verdict is conditional: SnagRX has a source-backed Semaglutide offer, while the final purchase decision still depends on current checkout terms, state access, clinical review, and dispensing details.

Readers deciding whether SnagRx belongs on their compounded semaglutide shortlist and who need treatment-level facts before comparing providers. If the provider page or checkout disagrees with the dated information here, ask for the current product, total charge and renewal terms in writing. Resolve the difference before paying instead of relying on the older figure.

Common questions

SnagRX Semaglutide FAQ

What amount is currently published for SnagRX Semaglutide?
The linked price source lists $99 a month, continuing for Compounded semaglutide injection, checked 22 October 2026. The amount should be read with any introduction, prepayment, or commitment shown in the same offer record. It is a dated published commercial fact, not a promise that every checkout configuration, future renewal, or product change will cost the same amount.
What must checkout confirm in the SnagRX figure?
The published SnagRX offer includes medication for Semaglutide. That does not establish that the price includes labs, every consultation, supplies, faster shipping, dose-related price changes, or a future refill. Confirm those items and the complete charge in the selected checkout before treating the figure as all-inclusive.
Does this guide cover other formulations for SnagRX Semaglutide?
This guide covers Compounded semaglutide injection in Weekly subcutaneous injection format. It does not transfer price, regulatory status, evidence, convenience, dosing, pharmacy, or fulfillment claims to another Semaglutide formulation or to a related product. Compare route and product identity before comparing the price because similar medication names can still describe materially different offers.
Is access guaranteed for SnagRX Semaglutide?
Published availability lists Louisiana as restricted for this type of treatment. Confirm eligibility directly because provider coverage can change. A published state list is only one part of eligibility. SnagRX must also confirm clinician licensure, product eligibility, and pharmacy fulfillment for the specific Semaglutide prescription. Completing an intake does not guarantee approval, dispensing, or a particular outcome.
Where can I compare current provider prices for SnagRX Semaglutide?
Use the Semaglutide comparison to check the dated prices, product formats and plan terms across providers. Compare SnagRX only with offers that disclose the same price components, medication inclusion, commitment, and format; otherwise explain why the rows are not directly equivalent.

Sources and method

Telehealth Ledger checked provider pages, plan terms, and independent context on 22 October 2026. This page compares published commercial terms. It is not a rating, medical advice, or a guarantee that a clinician will prescribe treatment.